# Top 20 Outreach List - Built Simple APIs

**Generated:** 2026-01-31  
**APIs:** PubMed, ArXiv, Wikipedia, FixIt  
**Search budget used:** ~20 queries (of 40-50 allocated)

---

## Quick Reference Table

| Rank | Company | Valuation/Funding | API Fit | Decision Maker | Location | Priority |
|------|---------|-------------------|---------|----------------|----------|----------|
| 1 | OpenEvidence | $12B | PubMed | Daniel Nadler (CEO) | US | ðŸ”¥ðŸ”¥ðŸ”¥ |
| 2 | Glean | $7.2B | Wikipedia | Arvind Jain (CEO) | US | ðŸ”¥ðŸ”¥ðŸ”¥ |
| 3 | Cohere | $6.8B | ArXiv + Wikipedia | Nils Reimers (VP Embeddings) | Canada | ðŸ”¥ðŸ”¥ðŸ”¥ |
| 4 | Viz.ai | $5.3B | PubMed | Chris Mansi (CEO) | US | ðŸ”¥ðŸ”¥ðŸ”¥ |
| 5 | Hippocratic AI | $3.5B | PubMed | Munjal Shah (CEO) | US | ðŸ”¥ðŸ”¥ðŸ”¥ |
| 6 | Together AI | $3.3B | ArXiv | Ce Zhang (CTO) | US | ðŸ”¥ðŸ”¥ðŸ”¥ |
| 7 | Runway | $3B | ArXiv | CristÃ³bal Valenzuela (CEO) | US | ðŸ”¥ðŸ”¥ |
| 8 | LangChain | $1.25B | Wikipedia + ArXiv | Harrison Chase (CEO) | US | ðŸ”¥ðŸ”¥ðŸ”¥ |
| 9 | insitro | $400M+ raised | PubMed | Philip Tagari (CSO) | US | ðŸ”¥ðŸ”¥ |
| 10 | Truveta | $1B | PubMed | Terry Myerson (CEO) | US | ðŸ”¥ðŸ”¥ |
| 11 | SambaNova | $1.1B+ raised | ArXiv | Kunle Olukotun (Chief Tech) | US | ðŸ”¥ðŸ”¥ |
| 12 | Recursion | Public (RXRX) | PubMed | Najat Khan (CEO) | US | ðŸ”¥ðŸ”¥ |
| 13 | SchrÃ¶dinger | Public (SDGR) | PubMed | Patrick Lorton (CTO) | US | ðŸ”¥ðŸ”¥ |
| 14 | Tempus | Public (TEM) | PubMed | Eric Lefkofsky (CEO) | US | ðŸ”¥ðŸ”¥ |
| 15 | PathAI | $255M raised | PubMed | Andy Beck (CEO) | US | ðŸ”¥ðŸ”¥ |
| 16 | Modular | $250M raised | ArXiv | Chris Lattner (CEO) | US | ðŸ”¥ðŸ”¥ |
| 17 | Anyscale | $259M raised | ArXiv | Robert Nishihara (CEO) | US | ðŸ”¥ |
| 18 | Pinecone | $138M raised | Wikipedia | Edo Liberty (CEO) | US | ðŸ”¥ |
| 19 | LlamaIndex | $19M Series A | Wikipedia + ArXiv | Jerry Liu (CEO) | US | ðŸ”¥ðŸ”¥ |
| 20 | Deepset | $30M+ raised | Wikipedia + ArXiv | Malte Pietsch (CTO) | Germany | ðŸ”¥ |

---

## Detailed Lead Notes

### 1. OpenEvidence ðŸ”¥ðŸ”¥ðŸ”¥
**Valuation:** $12B (Jan 2026)  
**HQ:** US  
**What they do:** AI copilot for doctors - "ChatGPT for physicians". Most widely used medical AI among US doctors. Partners with NEJM, JAMA, NCCN.

| Role | Name | LinkedIn |
|------|------|----------|
| Founder & CEO | Daniel Nadler, PhD | [LinkedIn](https://linkedin.com/in/daniel-nadler) |

**Why PubMed API:** Their ENTIRE product is clinical decision support powered by medical literature. They need fast, reliable access to the latest medical research to power real-time recommendations.

**Recent Hook:** Daniel Nadler became a billionaire in 2025 when valuation hit $3.5B, now worth ~$3.6B after $12B valuation. Company is the fastest-growing medical AI - perfect timing.

**Outreach Angle:** "Your physicians need answers in seconds. Our PubMed API delivers 10x faster literature search than alternatives. We power [X] million queries/month for similar use cases."

**Email Pattern:** firstname@openevidence.com

---

### 2. Glean ðŸ”¥ðŸ”¥ðŸ”¥
**Valuation:** $7.2B (Series F, June 2025)  
**HQ:** Palo Alto, CA  
**What they do:** AI-powered enterprise search and assistant. Used by major enterprises for knowledge retrieval.

| Role | Name | LinkedIn |
|------|------|----------|
| CEO & Founder | Arvind Jain | [LinkedIn](https://linkedin.com/in/arvindjain1) |
| CTO & Co-founder | T.R. Vishwanath | [LinkedIn](https://linkedin.com/in/trvishwanath) |
| Head of Product | Emrecan Dogan | [LinkedIn](https://linkedin.com/in/emrecandogan) |

**Why Wikipedia API:** Glean aggregates enterprise knowledge - adding structured encyclopedic content would enhance their AI assistant's ability to answer factual questions with grounded, verifiable info.

**Recent Hook:** Series F at $7.2B in June 2025 - they're scaling fast and adding new data sources.

**Outreach Angle:** "Glean's enterprise search could ground AI responses in verified encyclopedic knowledge. Wikipedia API gives your AI assistant a factual foundation beyond internal docs."

**Email Pattern:** firstname@glean.com (or demo request)

---

### 3. Cohere ðŸ”¥ðŸ”¥ðŸ”¥
**Valuation:** $6.8B (Aug 2025)  
**Total Funding:** $500M+ round  
**HQ:** Toronto, Canada  
**What they do:** Enterprise LLM platform with foundation models. Building Command, Embed, and Rerank models.

| Role | Name | LinkedIn | Notes |
|------|------|----------|-------|
| Chief AI Officer | Joelle Pineau | [LinkedIn](https://linkedin.com/in/joelle-pineau) | **NEW HIRE** - ex-Head of Meta FAIR |
| CTO | Phil Blunsom | [LinkedIn](https://linkedin.com/in/philblunsom) | |
| VP, Embeddings & Search | Nils Reimers | [LinkedIn](https://linkedin.com/in/nils-reimers) | **BEST CONTACT** - owns search/retrieval |

**Why ArXiv + Wikipedia API:** 
- ArXiv: Their research team needs continuous access to ML papers for model development
- Wikipedia: Their RAG/retrieval products need high-quality knowledge sources

**Recent Hook:** Just hired Joelle Pineau (former Meta FAIR head) as Chief AI Officer in Aug 2025. Major research credibility boost.

**Outreach Angle:** "Nils - saw your work on sentence transformers. Our ArXiv API could power Cohere's research workflows, and Wikipedia API could enhance Command's factual grounding."

**Email Pattern:** firstname@cohere.com

---

### 4. Viz.ai ðŸ”¥ðŸ”¥ðŸ”¥
**Valuation:** $5.3B (Series E, June 2025)  
**Funding:** $300M Series E  
**HQ:** San Francisco, CA  
**What they do:** AI-powered care coordination for stroke, cardiovascular conditions. FDA-cleared. Used by 150+ health systems, 55 specialties, 28 languages.

| Role | Name | LinkedIn |
|------|------|----------|
| CEO & Co-Founder | Chris Mansi, MD, MBA | [LinkedIn](https://linkedin.com/in/chrismansimd/) |
| Chief Clinical Officer | Andrew M. Ibrahim MD | [LinkedIn](https://linkedin.com/in/andrewibrahim/) |
| VP R&D | Oded Cohen | [LinkedIn](https://linkedin.com/in/oded-cohen-78678a17) |

**Why PubMed API:** Clinical AI needs medical literature integration for evidence-based recommendations. Expanding to 55 specialties means they need comprehensive medical literature access.

**Recent Hook:** Just raised $300M at $5.3B valuation in June 2025. Massive expansion across specialties.

**Outreach Angle:** "As Viz.ai expands to 55 specialties, PubMed API can power evidence-based clinical recommendations at scale. We handle [X] req/sec for similar FDA-regulated workloads."

**Email Pattern:** firstname@viz.ai

---

### 5. Hippocratic AI ðŸ”¥ðŸ”¥ðŸ”¥
**Valuation:** $3.5B (Series C, Nov 2025)  
**Total Funding:** $404M  
**HQ:** US  
**What they do:** Safety-focused generative AI healthcare agents. Building clinical AI for "healthcare abundance."

| Role | Name | LinkedIn | Notes |
|------|------|----------|-------|
| CEO & Co-Founder | Munjal Shah | [LinkedIn](https://linkedin.com/in/munjal) | Ex-Google (sold Like.com) |
| COO | Dan Kendall | [LinkedIn](https://linkedin.com/in/dankendall) | Ex-COO El Camino Health |

**Why PubMed API:** Medical AI agents need reliable, real-time literature access for evidence-based responses. Safety-focused = needs verified medical sources.

**Recent Hook:** Series C closed Nov 2025 at $3.5B. Andreessen Horowitz's Julie Yoo called them "one of the fastest-growing enterprise healthcare companies" ever.

**Outreach Angle:** "Hippocratic's safety-first approach needs verified medical literature. Our PubMed API delivers peer-reviewed evidence with sub-100ms latency for real-time agent responses."

**Email Pattern:** firstname@hippocraticai.com

---

### 6. Together AI ðŸ”¥ðŸ”¥ðŸ”¥
**Valuation:** $3.3B (Series B, Feb 2025)  
**Total Funding:** $534M  
**HQ:** San Francisco, CA  
**What they do:** Open-source LLM infrastructure. Training and serving open models at scale.

| Role | Name | LinkedIn | Notes |
|------|------|----------|-------|
| Founder & CTO | Ce Zhang | [LinkedIn](https://linkedin.com/in/cezhang) | Best technical contact |
| Chief Scientist | Tri Dao | [LinkedIn](https://linkedin.com/in/tridao) | FlashAttention inventor |
| VP of Research | Leon Song | [LinkedIn](https://linkedin.com/in/leonsong) | |

**Why ArXiv API:** Research-first company training open LLMs. They actively publish papers and need continuous access to latest ML research for model development.

**Recent Hook:** $305M Series B in Feb 2025, valued at $3.3B. Nvidia is an investor.

**Outreach Angle:** "Together's research team needs real-time ArXiv access. Our API delivers structured paper search + metadata - perfect for training data curation and competitive analysis."

**Email Pattern:** firstname@together.ai

---

### 7. Runway ðŸ”¥ðŸ”¥
**Valuation:** $3B (Series D, Apr 2025)  
**Funding:** $308M  
**HQ:** New York, NY  
**What they do:** Generative AI for video. Building "world simulators" and Gen-3 video models.

| Role | Name | LinkedIn |
|------|------|----------|
| Co-Founder & CEO | CristÃ³bal Valenzuela | [LinkedIn](https://linkedin.com/in/cvalenzuelab) |
| Co-Founder | Anastasis Germanidis | [LinkedIn](https://linkedin.com/in/anastasisgermanidis) |

**Why ArXiv API:** Cutting-edge research lab publishing on world models, video generation. Their research team needs paper access for competitive analysis and model development.

**Recent Hook:** $308M Series D in April 2025. Building "world simulators" - pushing boundaries of video AI.

**Outreach Angle:** "Runway's research on world models needs ArXiv integration. Our API powers automated paper tracking for ML research teams at [similar companies]."

**Email Pattern:** firstname@runwayml.com

---

### 8. LangChain ðŸ”¥ðŸ”¥ðŸ”¥
**Valuation:** $1.25B (Series B, Oct 2025)  
**Funding:** $125M  
**HQ:** San Francisco, CA  
**What they do:** Leading LLM application framework. 90M+ monthly downloads. LangSmith for agent engineering.

| Role | Name | LinkedIn |
|------|------|----------|
| CEO & Co-Founder | Harrison Chase | [LinkedIn](https://linkedin.com/in/harrison-chase) |
| CTO | Ankush Gola | [LinkedIn](https://linkedin.com/in/ankushgola) |

**Why Wikipedia + ArXiv API:** 
- Wikipedia: RAG applications need reliable knowledge sources. Pre-built Wikipedia loader would benefit entire ecosystem.
- ArXiv: Developers building research assistants need paper access.

**Recent Hook:** Just hit unicorn status with $125M Series B in Oct 2025. "Three years of building LangChain" blog post shows they're doubling down on LangSmith.

**Outreach Angle:** "Harrison - Wikipedia and ArXiv APIs could be native LangChain document loaders. One integration = thousands of devs with reliable knowledge sources for RAG."

**Email Pattern:** firstname@langchain.dev

---

### 9. insitro ðŸ”¥ðŸ”¥
**Funding:** $400M+ Series C  
**HQ:** South San Francisco, CA  
**What they do:** AI therapeutics, causal biology, drug discovery. Using ML to decode disease biology.

| Role | Name | LinkedIn | Notes |
|------|------|----------|-------|
| CEO & Founder | Daphne Koller | [LinkedIn](https://linkedin.com/in/daphne-koller-4053a820) | Stanford AI legend |
| Chief Scientific Officer | Philip Tagari | [LinkedIn](https://linkedin.com/in/philip-tagari-793719b) | **PROMOTED from Head of Drug Discovery** |

**Why PubMed API:** Integrates ML models with biological literature for target discovery. Drug discovery requires continuous literature mining for competitive intelligence.

**Recent Hook:** Just acquired CombinAbleAI (~3 weeks ago) to complete their AI platform. Philip Tagari now CSO.

**Outreach Angle:** "Philip - congrats on the CombinAbleAI acquisition. As insitro's AI platform expands, PubMed API can power real-time literature integration for target validation workflows."

**Email Pattern:** firstname@insitro.com

---

### 10. Truveta ðŸ”¥ðŸ”¥
**Valuation:** $1B (Jan 2025)  
**Funding:** $320M  
**HQ:** Seattle, WA  
**What they do:** EHR data and analytics from 130M+ patients. Real-world evidence for clinical research. Backed by major health systems.

| Role | Name | LinkedIn | Notes |
|------|------|----------|-------|
| CEO & Co-Founder | Terry Myerson | [LinkedIn](https://linkedin.com/in/terrymyerson) | Ex-EVP Microsoft Windows |
| CTO & Co-Founder | Jay Nanduri | [LinkedIn](https://linkedin.com/in/jaynanduri) | Ex-Microsoft Technical Fellow |
| President & CSO | Johnathan Lancaster, MD, PhD | [LinkedIn](https://linkedin.com/in/johnathanlancaster) | |

**Why PubMed API:** Research platform combining patient data with literature context. 130M patients need literature grounding for research insights.

**Recent Hook:** $320M funding in Jan 2025, Regeneron and Illumina among investors. Building genetic database.

**Outreach Angle:** "Terry - Truveta's research platform could integrate real-time PubMed search. Correlate your 130M patient EHR data with relevant medical literature automatically."

**Email Pattern:** firstname@truveta.com

---

### 11. SambaNova ðŸ”¥ðŸ”¥
**Funding:** $1.1B+ total  
**HQ:** Palo Alto, CA  
**What they do:** AI hardware/cloud. Building AI supercomputers with custom chips.

| Role | Name | LinkedIn | Notes |
|------|------|----------|-------|
| Co-Founder & Chief Technologist | Kunle Olukotun | [LinkedIn](https://linkedin.com/in/kunleolukotun) | Stanford EE Professor |
| CEO | Rodrigo Liang | [LinkedIn](https://linkedin.com/in/rodrigoliang) | |

**Why ArXiv API:** Research team working on next-gen AI architectures. Academic roots (Stanford AI Lab) means deep research culture.

**Outreach Angle:** "Kunle - SambaNova's research team could benefit from ArXiv API for tracking ML optimization papers. We power research workflows at similar AI labs."

**Email Pattern:** firstname@sambanova.ai

---

### 12. Recursion ðŸ”¥ðŸ”¥
**Status:** Public (NASDAQ: RXRX)  
**HQ:** Salt Lake City, UT  
**What they do:** AI drug discovery at scale. 65+ petabytes of biological data. BioHive-2 supercomputer.

| Role | Name | LinkedIn | Notes |
|------|------|----------|-------|
| CEO | Najat Khan | [LinkedIn](https://linkedin.com/in/najatkhan) | **NEW CEO as of Nov 2025** |
| Chairman | Chris Gibson, PhD | [LinkedIn](https://linkedin.com/in/chrisgibsonphd) | Former CEO, transitioned Nov 2025 |

**Why PubMed API:** 65PB of bio data needs literature integration. BioHive-2 workflows would benefit from automated literature search.

**Recent Hook:** CEO transition Nov 2025 - Najat Khan took over from Chris Gibson. New leadership = opportunity.

**Outreach Angle:** "Najat - congrats on the new role. As Recursion scales BioHive-2, PubMed API can integrate literature search into your drug discovery workflows at petabyte scale."

**Email Pattern:** firstname@recursion.com

---

### 13. SchrÃ¶dinger ðŸ”¥ðŸ”¥
**Status:** Public (NASDAQ: SDGR)  
**HQ:** New York, NY  
**What they do:** Physics-based molecular simulation for drug design. Leading computational chemistry platform.

| Role | Name | LinkedIn |
|------|------|----------|
| CTO & COO (Software) | Patrick Lorton | [LinkedIn](https://linkedin.com/in/pat-lorton-9a07399/) |
| President & CEO | Ramy Farid, PhD | [LinkedIn](https://linkedin.com/in/ramyfarid) |

**Why PubMed API:** Literature mining for target validation, competitive intelligence. Physics-based modeling needs experimental literature context.

**Recent Hook:** NVIDIA partnership to accelerate drug discovery. Presenting at BioIT World 2025.

**Outreach Angle:** "Patrick - SchrÃ¶dinger's computational platform could benefit from integrated literature search. PubMed API enables real-time target validation against published research."

**Email Pattern:** firstname@schrodinger.com

---

### 14. Tempus ðŸ”¥ðŸ”¥
**Status:** Public (NASDAQ: TEM, ~$64/share Dec 2025)  
**HQ:** Chicago, IL  
**What they do:** AI precision medicine platform. Oncology focus. Data-driven diagnostics and research.

| Role | Name | LinkedIn |
|------|------|----------|
| Founder & CEO | Eric Lefkofsky | [LinkedIn](https://linkedin.com/in/ericlefkofsky) |

**Why PubMed API:** Cancer research and clinical decision support require literature access. Precision medicine needs evidence-based recommendations.

**Outreach Angle:** "Eric - Tempus oncology platform could integrate real-time PubMed search for clinical evidence. Power treatment recommendations with latest cancer research."

**Email Pattern:** firstname@tempus.com

---

### 15. PathAI ðŸ”¥ðŸ”¥
**Funding:** $255M total  
**HQ:** Boston, MA  
**What they do:** AI-powered pathology. Building foundation models for computational pathology. FDA-cleared.

| Role | Name | LinkedIn |
|------|------|----------|
| Co-founder & CEO | Andy Beck, MD, PhD | [LinkedIn](https://linkedin.com/in/andrew-beck-a77328aa) |

**Why PubMed API:** Pathology research, clinical validation literature. FDA clearance requires evidence documentation.

**Recent Hook:** "What a year at PathAI. In 2025, we didn't just talk about digital pathologyâ€”we built it." (LinkedIn post)

**Outreach Angle:** "Andy - PathAI's digital pathology platform could integrate PubMed for automated literature review. Accelerate FDA submissions with evidence aggregation."

**Email Pattern:** firstname@pathai.com

---

### 16. Modular ðŸ”¥ðŸ”¥
**Funding:** $250M (Sept 2025)  
**HQ:** San Francisco, CA  
**What they do:** Next-gen AI infrastructure. Mojo programming language. Taking on NVIDIA's AI software monopoly.

| Role | Name | LinkedIn | Notes |
|------|------|----------|-------|
| Co-Founder & CEO | Chris Lattner | [LinkedIn](https://linkedin.com/in/chrisattner) | Created LLVM, Swift, MLIR |
| Co-Founder & President | Tim Davis | [LinkedIn](https://linkedin.com/in/timdavis) | |

**Why ArXiv API:** Building cutting-edge AI infrastructure. Chris Lattner's engineering culture values research. Team from Google, Apple.

**Recent Hook:** $250M funding in Sept 2025 to challenge NVIDIA. Business Insider feature in Dec 2025.

**Outreach Angle:** "Chris - Modular's engineering team could use ArXiv API for tracking ML compiler papers. We power research workflows at similar infrastructure companies."

**Email Pattern:** firstname@modular.com

---

### 17. Anyscale ðŸ”¥
**Funding:** $259M Series C  
**HQ:** San Francisco, CA  
**What they do:** Ray ML infrastructure. Used by OpenAI, Uber, Shopify for distributed ML.

| Role | Name | LinkedIn | Notes |
|------|------|----------|-------|
| CEO | Robert Nishihara | [LinkedIn](https://linkedin.com/in/robertnishihara) | Ray co-creator |
| Co-Founder | Ion Stoica | [LinkedIn](https://linkedin.com/in/ionstoica) | UC Berkeley legend |

**Why ArXiv API:** Research teams using Ray need paper access. UC Berkeley origins = strong academic culture.

**Recent Hook:** Ray joined PyTorch Foundation (Oct 2025). Major ecosystem integration.

**Outreach Angle:** "Robert - congrats on Ray joining PyTorch Foundation. ArXiv API could power research discovery for the Ray ecosystem."

**Email Pattern:** firstname@anyscale.com

---

### 18. Pinecone ðŸ”¥
**Valuation:** $750M  
**Funding:** $138M  
**HQ:** San Francisco, CA  
**What they do:** Leading managed vector database for AI. Powers semantic search and RAG at scale.

| Role | Name | LinkedIn |
|------|------|----------|
| Founder & CEO | Edo Liberty | [LinkedIn](https://linkedin.com/in/edoliberty) |

**Why Wikipedia API:** Vector search company - their customers frequently embed and search Wikipedia content. Partnership opportunity.

**Outreach Angle:** "Edo - Pinecone customers often ask about Wikipedia embedding. Pre-indexed Wikipedia via our API could be a value-add for RAG use cases."

**Email Pattern:** firstname@pinecone.io

---

### 19. LlamaIndex ðŸ”¥ðŸ”¥
**Funding:** $19M Series A (Mar 2025)  
**HQ:** San Francisco, CA  
**What they do:** Leading RAG framework. 25M+ package downloads/month. 500M+ documents processed.

| Role | Name | LinkedIn |
|------|------|----------|
| CEO & Co-Founder | Jerry Liu | [LinkedIn](https://linkedin.com/in/jerry-liu-64390071) |
| Co-Founder | Simon Suo | [LinkedIn](https://linkedin.com/in/simonsuo) |

**Why Wikipedia + ArXiv API:** RAG-focused company. ArXiv and Wikipedia are natural document sources. High strategic value - integration benefits entire ecosystem.

**Recent Hook:** $19M Series A in March 2025. Growing fast.

**Outreach Angle:** "Jerry - Wikipedia and ArXiv APIs could be native LlamaIndex connectors. One integration = millions of developers with reliable knowledge sources."

**Email Pattern:** firstname@llamaindex.ai

---

### 20. Deepset (Haystack) ðŸ”¥
**Funding:** $30M+ Series A  
**HQ:** Berlin, Germany  
**What they do:** Haystack open-source RAG framework + enterprise platform. NLP/search pioneers since 2018.

| Role | Name | LinkedIn |
|------|------|----------|
| CEO & Co-Founder | Milos Rusic | [LinkedIn](https://linkedin.com/in/milosrusic) |
| CTO & Co-Founder | Malte Pietsch | [LinkedIn](https://linkedin.com/in/maltepietsch) |
| VP Marketing & DevRel | Jay Wilder | [LinkedIn](https://linkedin.com/in/jaywilder) |

**Why Wikipedia + ArXiv API:** Leading open-source RAG framework. Pre-built connector would add value for entire Haystack ecosystem.

**Note:** Germany-based but EU business hours overlap. Strong developer community.

**Outreach Angle:** "Malte - Haystack could benefit from pre-built Wikipedia and ArXiv connectors. We'd love to collaborate on integration examples for the community."

**Email Pattern:** firstname@deepset.ai

---

## Companies Excluded (and Why)

| Company | Reason |
|---------|--------|
| Groq | Being acquired by NVIDIA for ~$20B (Dec 2025) |
| Weights & Biases | Acquired by CoreWeave (Mar 2025) |
| Mistral AI | Paris, France - timezone mismatch |
| AI21 Labs | Tel Aviv, Israel - timezone mismatch |
| Isomorphic Labs | London, UK - timezone mismatch |

---

## Outreach Strategy by API

### PubMed API Targets (Healthcare/Biotech)
1. OpenEvidence ($12B) - clinical AI copilot
2. Viz.ai ($5.3B) - care coordination
3. Hippocratic AI ($3.5B) - healthcare agents
4. insitro ($400M+) - drug discovery
5. Truveta ($1B) - clinical research
6. Recursion (public) - AI drug discovery
7. SchrÃ¶dinger (public) - molecular simulation
8. Tempus (public) - precision medicine
9. PathAI ($255M) - AI pathology

### ArXiv API Targets (AI/ML Research)
1. Together AI ($3.3B) - open LLM training
2. Runway ($3B) - video generation research
3. Cohere ($6.8B) - foundation models
4. SambaNova ($1.1B+) - AI hardware
5. Modular ($250M) - AI infrastructure
6. Anyscale ($259M) - Ray ML framework

### Wikipedia API Targets (Knowledge/RAG)
1. Glean ($7.2B) - enterprise search
2. LangChain ($1.25B) - LLM framework
3. LlamaIndex ($19M) - RAG framework
4. Deepset ($30M+) - Haystack
5. Pinecone ($138M) - vector database
6. Cohere ($6.8B) - enterprise LLM

---

## Suggested Outreach Order

**Week 1 (highest urgency):**
1. OpenEvidence - $12B, perfect PubMed fit
2. LangChain - ecosystem play, multiplier effect
3. Hippocratic AI - hot Series C, PubMed perfect fit
4. Together AI - research-first, ArXiv fit

**Week 2:**
5. Glean - $7.2B Wikipedia fit
6. Cohere - dual API opportunity
7. Viz.ai - $5.3B PubMed fit
8. insitro - recent acquisition hook

**Week 3:**
9. LlamaIndex - ecosystem play
10. Recursion - new CEO hook
11. Truveta - new funding hook
12. Runway - research team

**Week 4:**
13-20. Remaining targets

---

*Generated 2026-01-31. Verify contact details before outreach.*
